Published in J Appl Physiol (1985) on December 10, 2009
Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes. Pediatr Diabetes (2011) 1.51
Inflammatory cytokine profiles during exercise in obese, diabetic, and healthy children. J Clin Res Pediatr Endocrinol (2011) 0.87
Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial. PLoS One (2014) 0.82
Aerobic and combined exercise sessions reduce glucose variability in type 2 diabetes: crossover randomized trial. PLoS One (2013) 0.81
Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome. J Inflamm (Lond) (2012) 0.80
Fasting glucose level modulates cell surface expression of CD11b and CD66b in granulocytes and monocytes of patients with type 2 diabetes. J Investig Med (2013) 0.78
Altered molecular adaptation to exercise in children with type 1 diabetes: beyond hypoglycemia. Pediatr Diabetes (2008) 0.76
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
A self-report measure of pubertal status: Reliability, validity, and initial norms. J Youth Adolesc (1988) 12.12
Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med (2007) 11.62
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med (2000) 10.05
Diagnosis and classification of diabetes mellitus. Diabetes Care (2009) 7.66
The anti-inflammatory effect of exercise. J Appl Physiol (1985) (2005) 6.87
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation (2002) 6.26
Oxidative stress and diabetic vascular complications. Diabetes Care (1996) 5.97
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes (1999) 5.96
Anti-inflammatory cytokines. Chest (2000) 4.74
Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation (2003) 4.67
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med (2008) 4.25
Multiple comparison procedures updated. Clin Exp Pharmacol Physiol (1998) 3.92
The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther (2003) 3.27
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr (2001) 2.98
Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol (2005) 2.88
Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes (2006) 2.65
Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes (2005) 2.61
Role of myokines in exercise and metabolism. J Appl Physiol (1985) (2007) 2.52
Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA (2001) 2.37
Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol (1999) 2.17
Aerobic parameters of exercise as a function of body size during growth in children. J Appl Physiol Respir Environ Exerc Physiol (1984) 2.09
Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des (2005) 2.06
Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes (2004) 2.03
Glucose control by the kidney: an emerging target in diabetes. Am J Kidney Dis (2009) 1.83
Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem (2008) 1.76
Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care (2003) 1.75
Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes (2004) 1.73
Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatr Diabetes (2008) 1.68
Type 1 diabetes: pathogenesis and prevention. CMAJ (2006) 1.30
Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J (2004) 1.29
Muscle cytokine mRNA changes after 2.5 h of cycling: influence of carbohydrate. Med Sci Sports Exerc (2005) 1.27
Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes (2008) 1.13
Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. Pediatrics (2002) 1.09
Exercise, stress, and inflammation in the growing child: from the bench to the playground. Curr Opin Pediatr (2004) 1.03
Effect of antecedent hypoglycemia on counterregulatory responses to subsequent euglycemic exercise in type 1 diabetes. Diabetes (2003) 1.01
Reduced exercise-associated response of the GH-IGF-I axis and catecholamines in obese children and adolescents. J Appl Physiol (1985) (2005) 1.00
Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes. Ann Med (2008) 0.98
Adipokine expression profile in adipocytes of different mouse models of obesity. Horm Metab Res (2005) 0.97
Exercise in children and adolescents with diabetes. Pediatr Diabetes (2008) 0.96
Inflammatory cytokine, growth factor and counterregulatory responses to exercise in children with type 1 diabetes and healthy controls. Pediatr Diabetes (2006) 0.96
Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes. Am J Physiol Endocrinol Metab (2005) 0.90
Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes. J Cardiovasc Pharmacol (2007) 0.89
Tissue expression and plasma concentrations of TNFalpha, IL-1beta, and IL-6 following treadmill exercise in mice. Int J Sports Med (2001) 0.87
Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes. Am J Physiol Endocrinol Metab (2006) 0.85
Exercise leukocyte profiles in healthy, type 1 diabetic, overweight, and asthmatic children. Pediatr Exerc Sci (2009) 0.85
The oxidative stress of hyperglycemia and the inflammatory process in endothelial cells. J Med Invest (2009) 0.82
Increased inflammatory response of blood cells to repeated bout of endurance exercise. Med Sci Sports Exerc (2006) 0.78
Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatr Diabetes (2008) 1.68
Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes. Pediatr Diabetes (2011) 1.51
Rumination and cortisol responses to laboratory stressors. Psychosom Med (2008) 1.13
Inflammatory cytokine, growth factor and counterregulatory responses to exercise in children with type 1 diabetes and healthy controls. Pediatr Diabetes (2006) 0.96
Increased oxidative stress and altered substrate metabolism in obese children. Int J Pediatr Obes (2010) 0.93
Noninvasive measurement of plasma glucose from exhaled breath in healthy and type 1 diabetic subjects. Am J Physiol Endocrinol Metab (2011) 0.92
Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions. Pharmacol Ther (2008) 0.89
Improved predictive models for plasma glucose estimation from multi-linear regression analysis of exhaled volatile organic compounds. J Appl Physiol (1985) (2009) 0.88
Inflammatory cytokine profiles during exercise in obese, diabetic, and healthy children. J Clin Res Pediatr Endocrinol (2011) 0.87
Circulating T-regulatory cells, exercise and the elite adolescent swimmer. Pediatr Exerc Sci (2009) 0.87
Cytokines and growth factors during and after a wrestling season in adolescent boys. Med Sci Sports Exerc (2004) 0.86
Exercise leukocyte profiles in healthy, type 1 diabetic, overweight, and asthmatic children. Pediatr Exerc Sci (2009) 0.85
Altered kinetics of interleukin-6 and other inflammatory mediators during exercise in children with type 1 diabetes. J Investig Med (2008) 0.84
Pro-HEART - a randomized clinical trial to test the effectiveness of a high protein diet targeting obese individuals with heart failure: rationale, design and baseline characteristics. Contemp Clin Trials (2013) 0.83
Dose-dependent relationship between severity of pediatric obesity and blunting of the growth hormone response to exercise. J Appl Physiol (1985) (2009) 0.83
Exercise and leukocyte interchange among central circulation, lung, spleen, and muscle. Brain Behav Immun (2011) 0.83
Bone mineral density and leg muscle strength in young Caucasian, Hispanic, and Asian women. J Clin Densitom (2007) 0.82
Growth inhibition and compensation in response to neonatal hypoxia in rats. Pediatr Res (2013) 0.81
Ex vivo TCR-induced leukocyte gene expression of inflammatory mediators is increased in type 1 diabetic patients but not in overweight children. Diabetes Metab Res Rev (2010) 0.80
Fasting glucose level modulates cell surface expression of CD11b and CD66b in granulocytes and monocytes of patients with type 2 diabetes. J Investig Med (2013) 0.78
Synergistic effect of obesity and lipid ingestion in suppressing the growth hormone response to exercise in children. J Appl Physiol (1985) (2012) 0.78
Increased rat neonatal activity influences adult cytokine levels and relative muscle mass. Pediatr Res (2010) 0.77
Yes, yes, IL-6: what else? J Appl Physiol (1985) (2010) 0.77
Noninvasive measurement of plasma triglycerides and free fatty acids from exhaled breath. J Diabetes Sci Technol (2012) 0.77
Kinetic profiles of 18 systemic pro- and anti-inflammatory mediators during and following exercise in children. J Pediatr Endocrinol Metab (2007) 0.76
Altered molecular adaptation to exercise in children with type 1 diabetes: beyond hypoglycemia. Pediatr Diabetes (2008) 0.76
Acute suppression of circulating sCD40L during hyperglycemia and euglycemic-hyperinsulinemia in healthy young males. J Investig Med (2008) 0.75
Altered Monocyte Subtype Profiles Following High Intensity Exercise in Obese Children: 2657 Board #180 June 3, 9: 30 AM - 11: 00 AM. Med Sci Sports Exerc (2016) 0.75
Reduced Deoxyhemoglobin Threshold In The Prefrontal Cortex In Obese vs. Healthy Children: 513 Board #350 June 1, 9: 30 AM - 11: 00 AM. Med Sci Sports Exerc (2016) 0.75